Healthcare Reimbursement Global Market Report 2021 Featuring UnitedHealth, Aviva, Allianz, CVS, BNP Paribas, Aetna, Nippon Life Insurance, WellCare Health Plans, & Blue Cross Blue Shield – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--
The "Healthcare Reimbursement Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering.

The global healthcare reimbursement market is expected to decline from $15.19 billion in 2020 to $12.98 billion in 2021 at a compound annual growth rate (CAGR) of -14.5%. The decline is due to economic slowdown across countries owing to the COVID-19 outbreak and the measures to contain it. The market is expected to reach $23.02 billion in 2025 at a CAGR of 15%.

Major players in the healthcare reimbursement market are UnitedHealth Group, Aviva, Allianz, CVS Health, BNP Paribas, Aetna, Nippon Life Insurance, WellCare Health Plans, AgileHealthInsurance, and Blue Cross Blue Shield Association.

The healthcare reimbursement market consists of sales of healthcare reimbursement services by entities (organizations, sole traders and partnerships) that provide healthcare reimbursement services, which include the payment that hospitals, diagnostic facilities, doctors, or other health care providers receive for providing medical service to people. The healthcare reimbursement for a person's health care expenses is mostly covered partially or fully by the government or a health insurer. Only goods and services traded between entities or sold to end consumers are included.

Several incidences of fraud related to federal and state government health care programs hamper the growth of the healthcare reimbursement market. The medical insurance fraud and Medicare/Medicaid insurance fraud make up the majority of false claims in the USA. The National Health Care Anti-Fraud Association (NHCAA) reveals that unnecessary and duplicate tests and procedures, hacking into a patient's medical records to submit false claims, billing services never rendered, falsifying diagnosis are some common situations that occur.

According to the Department of Justice, one of the largest health care fraud enforcement actions across seven federal districts in the Northeastern United States, involved more than $800 million in loss and the distribution of over 3.25 million pills of opioids in ""pill mill"" clinics. The rise in healthcare fraud related to federal and state government programs create huge loss for the business restraining the growth of the healthcare reimbursement market.

The increasing cost of healthcare and supportive government programs are the key factors that are driving the healthcare reimbursement market growth. According to the Journal of the American Medical Association (JAMA), US healthcare costs are expected to reach $6 trillion, which is $17,000 per person by 2027. The rising healthcare cost and supportive government policies increase the number of people opting for payer services and thereby contributes to the growth of healthcare reimbursement market.

Companies in the healthcare reimbursement market are providing options of value-based care models to cater better experience for the patients. Value-based care models are based on the quality of patient's treatment and how well healthcare providers can improve their quality by adhering to certain metrics such as reducing hospital readmissions, improving preventative care, and using particular kinds of certified health technology and help lower healthcare costs.

Key Topics Covered:

1. Executive Summary

2. Healthcare Reimbursement Market Characteristics

3. Healthcare Reimbursement Market Trends and Strategies

4. Impact Of COVID-19 On Healthcare Reimbursement

5. Healthcare Reimbursement Market Size and Growth

5.1. Global Healthcare Reimbursement Historic Market, 2015-2020, $ Billion

5.1.1. Drivers Of the Market

5.1.2. Restraints On the Market

5.2. Global Healthcare Reimbursement Forecast Market, 2020-2025F, 2030F, $ Billion

5.2.1. Drivers Of the Market

5.2.2. Restraints On the Market

6. Healthcare Reimbursement Market Segmentation

6.1. Global Healthcare Reimbursement Market, Segmentation by Claims, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

• Underpaid
• Full Paid

6.2. Global Healthcare Reimbursement Market, Segmentation by Payers, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

• Private Payers
• Public Payers

6.3. Global Healthcare Reimbursement Market, Segmentation by Service Provider, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

• Physician office
• Hospitals
• Diagnostic Laboratories
• Others

7. Healthcare Reimbursement Market Regional and Country Analysis

7.1. Global Healthcare Reimbursement Market, Split by Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

7.2. Global Healthcare Reimbursement Market, Split by Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

Companies Mentioned

• UnitedHealth Group
• Aviva
• Allianz
• CVS Health
• BNP Paribas
• Aetna
• Nippon Life Insurance
• WellCare Health Plans
• AgileHealthInsurance
• Blue Cross Blue Shield Association

For more information about this report visit https://www.researchandmarkets.com/r/rhoe3d

src="https://cts.businesswire.com/ct/CT?id=bwnewssty=20220121005209r1sid=acqr8distro=nxlang=en" style="width:0;height:0" />

View source version on businesswire.com: https://www.businesswire.com/news/home/20220121005209/en/

ResearchAndMarkets.com
Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Source: Research and Markets